Nutrient Packed Pomegranate | Medindia - 0 views
-
Pomegranate has long been a valuable crop that produces nutritive fruits. The entire tree is of great economic importance. Loaded with vitamins C and B, potassium, folic acid and iron, the pomegranate is in true sense "a superfood". Above all, each edible seed of pomegranate is a source of fiber. With its delicious taste, easy availability, and relatively economic value, it sure is a soothing fruit for the stomach. Various studies also suggest that pomegranate is very rich in antioxidants, almost three times the antioxidants found in green tea or red wine.
Novartis launches Lucentis PFS in Germany - 1 views
-
PBR Staff Writer Published 21 March 2014 Novartis has launched the Lucentis (ranibizumab) pre-filled syringe (PFS) in Germany and plans to introduce the product in other markets throughout 2014. In October 2013, the company has received approval from the European authorities for Lucentis PFS, which is a new way of administering Lucentis that is specifically designed for intraocular injection to enhance patient safety and convenience for the treating clinician.
Developing Self Confidence In Children - 1 views
My husband and I were really worried with the indifference that our second child has been showing. We noticed that she did not like to mingle with other kids in the class. Her teacher even told us ...
CHA announces new program to accelerate innovation in life sciences and health care - 0 views
-
Published 25 February 2014 Cambridge Healthtech Associates (CHA) has announced a new program to accelerate innovation in life sciences and health care. Announcing the launch of the first-ever tool in life sciences and health care to evaluate and rank new technologies and services via an end-user process.
Eisai announces launch of Fycompa in Netherlands - 1 views
GlaxoSmithKline's once-weekly diabetes drug Eperzan gets marketing approval in Europe - 1 views
-
PBR Staff Writer Published 27 March 2014 The European Commission (EC) has granted marketing authorization for GlaxoSmithKline's (GSK's) once-weekly diabetes treatment, Eperzan (albiglutide). The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to contraindications or intolerance.